Review





Similar Products

visitect cd4 advanced hiv disease assay  (Partec)
86
Partec visitect cd4 advanced hiv disease assay
Visitect Cd4 Advanced Hiv Disease Assay, supplied by Partec, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/visitect cd4 advanced hiv disease assay/product/Partec
Average 86 stars, based on 1 article reviews
visitect cd4 advanced hiv disease assay - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
visitect cd4 semi quantitative lfa  (Partec)
86
Partec visitect cd4 semi quantitative lfa
Visitect Cd4 Semi Quantitative Lfa, supplied by Partec, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/visitect cd4 semi quantitative lfa/product/Partec
Average 86 stars, based on 1 article reviews
visitect cd4 semi quantitative lfa - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
visitect cd4  (Partec)
86
Partec visitect cd4
Visitect Cd4, supplied by Partec, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/visitect cd4/product/Partec
Average 86 stars, based on 1 article reviews
visitect cd4 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
visitect cd4 lfa  (Partec)
86
Partec visitect cd4 lfa
Visitect Cd4 Lfa, supplied by Partec, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/visitect cd4 lfa/product/Partec
Average 86 stars, based on 1 article reviews
visitect cd4 lfa - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
visitect® cd4 advanced  (Omega Diagnostics)
90
Omega Diagnostics visitect® cd4 advanced
Visitect® Cd4 Advanced, supplied by Omega Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/visitect® cd4 advanced/product/Omega Diagnostics
Average 90 stars, based on 1 article reviews
visitect® cd4 advanced - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
visitect® cd4 advanced disease assay  (Omega Diagnostics)
90
Omega Diagnostics visitect® cd4 advanced disease assay
Box‐ and whisker plots showing variations in reference <t>CD4</t> counts with WHO clinical HIV stage, presence or absence of TB suggestive symptoms, and VISITECT® CD4 Advanced Disease (VISITECT‐CD4‐AD).
Visitect® Cd4 Advanced Disease Assay, supplied by Omega Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/visitect® cd4 advanced disease assay/product/Omega Diagnostics
Average 90 stars, based on 1 article reviews
visitect® cd4 advanced disease assay - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
visitect® cd4 advanced disease test  (Omega Diagnostics)
90
Omega Diagnostics visitect® cd4 advanced disease test
Highlights of terms and conditions of the <t>VISITECT</t> EMAV.
Visitect® Cd4 Advanced Disease Test, supplied by Omega Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/visitect® cd4 advanced disease test/product/Omega Diagnostics
Average 90 stars, based on 1 article reviews
visitect® cd4 advanced disease test - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Box‐ and whisker plots showing variations in reference CD4 counts with WHO clinical HIV stage, presence or absence of TB suggestive symptoms, and VISITECT® CD4 Advanced Disease (VISITECT‐CD4‐AD).

Journal: Tropical Medicine & International Health

Article Title: VISITECT ® CD4 advanced disease assay in routine use: Diagnostic accuracy and usability, Ethiopia and Indonesia

doi: 10.1111/tmi.14124

Figure Lengend Snippet: Box‐ and whisker plots showing variations in reference CD4 counts with WHO clinical HIV stage, presence or absence of TB suggestive symptoms, and VISITECT® CD4 Advanced Disease (VISITECT‐CD4‐AD).

Article Snippet: Unfortunately, for commercial reasons, Pima was discontinued in 2022 and FACSPresto in 2023, leaving Omega Diagnostics' (UK) VISITECT® CD4 Advanced Disease assay (VISITECT‐CD4‐AD) as the only option currently for obtaining an estimate of a PLHIV's CD4 count at POC [ ].

Techniques: Whisker Assay

Specificity of VISITECT‐CD4‐AD with 95% confidence intervals, by study site: (a) Site‐specific specificity over total study period in all 10 health facilities. Size of marker indicates number of participants enrolled. (b) Specificity in Ethiopian health facilities before and after retraining.

Journal: Tropical Medicine & International Health

Article Title: VISITECT ® CD4 advanced disease assay in routine use: Diagnostic accuracy and usability, Ethiopia and Indonesia

doi: 10.1111/tmi.14124

Figure Lengend Snippet: Specificity of VISITECT‐CD4‐AD with 95% confidence intervals, by study site: (a) Site‐specific specificity over total study period in all 10 health facilities. Size of marker indicates number of participants enrolled. (b) Specificity in Ethiopian health facilities before and after retraining.

Article Snippet: Unfortunately, for commercial reasons, Pima was discontinued in 2022 and FACSPresto in 2023, leaving Omega Diagnostics' (UK) VISITECT® CD4 Advanced Disease assay (VISITECT‐CD4‐AD) as the only option currently for obtaining an estimate of a PLHIV's CD4 count at POC [ ].

Techniques: Marker

Highlights of terms and conditions of the VISITECT EMAV.

Journal: Health Policy OPEN

Article Title: The early market access vehicle – An innovative demand-driven model to catalyse introduction of new optimal health products in low- and middle-income countries

doi: 10.1016/j.hpopen.2024.100135

Figure Lengend Snippet: Highlights of terms and conditions of the VISITECT EMAV.

Article Snippet: EMAV for the VISITECT® CD4 Advanced Disease test : Developed by Omega Diagnostics, and now owned by AccuBio, VISITECT® is the world’s first true point of care lateral flow assay test that does not require an electronic device to produce a CD4 count result.

Techniques: